Preparation and applications of organo-silica hybrid mesoporous silica nanoparticles for the co-delivery of drugs and nucleic acids

Iris Pontón, Andrea Martí del Rio, Marta Gómez Gómez, David Sánchez-García

Producción científica: Artículo en revista indizadaRecensiónrevisión exhaustiva

14 Citas (Scopus)

Resumen

Combination therapies rely on the administration of more than one drug, with independent mechanisms of action, aiming to enhance the efficiency of the treatment. For an optimal performance, the implementation of such therapies requires the delivery of the correct combination of drugs to a specific cellular target. In this context, the use of nanoparticles (NP) as platforms for the co-delivery of multiple drugs is considered a highly promising strategy. In particular, mesoporous silica nanoparticles (MSN) have emerged as versatile building blocks to devise complex drug delivery systems (DDS). This review describes the design, synthesis, and application of MSNs to the delivery of multiple drugs including nucleic acids for combination therapies.

Idioma originalInglés
Número de artículo2466
Páginas (desde-hasta)1-37
Número de páginas37
PublicaciónNanomaterials
Volumen10
N.º12
DOI
EstadoPublicada - dic 2020

Huella

Profundice en los temas de investigación de 'Preparation and applications of organo-silica hybrid mesoporous silica nanoparticles for the co-delivery of drugs and nucleic acids'. En conjunto forman una huella única.

Citar esto